FDA Approves Bayer’s Low-Dose MRI Contrast Agent
The new agent is indicated for visualizing lesions in the central nervous system and other body regions for adult and pediatric patients.
The new agent is indicated for visualizing lesions in the central nervous system and other body regions for adult and pediatric patients.
Researchers found that oxalic acid—found in foods like spinach and nuts—may cause MRI dye to form toxic particles in the body, possibly explaining why some patients experience side effects.
Researchers used MRI to detect blood vessel dysfunction in the brain's temporal lobes, identifying microvascular abnormalities as potential early biomarkers for mild cognitive impairment and dementia, independent of Alzheimer’s-related changes.
Researchers found that higher visceral fat levels in midlife are linked to Alzheimer’s pathology and reduced brain blood flow, suggesting that lifestyle changes targeting visceral obesity could help prevent or delay the disease.
Read MoreSoccer heading may cause brain damage similar to that seen in neurodegenerative diseases, with repeated impacts linked to structural abnormalities and cognitive decline even without concussions, according to a new study.
Read MoreA study using advanced imaging suggests that impaired pulmonary gas exchange may be linked to cognitive dysfunction and altered brain structure in long COVID patients, highlighting a potential multiorgan relationship and treatment target.
Read MorePhilips will introduce its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024, which includes AI-enabled workflow tools, automated reporting for neurological and prostate conditions, and a helium-free design for broader accessibility and reduced installation requirements.
Read MoreE-cigarettes and traditional cigarettes both cause immediate harm to vascular function, even without nicotine, as demonstrated by advanced radiology techniques, highlighting potential long-term health risks.
Read More